THE CLINICAL SIGNIFICANCE OF COANALGESICS IN PAIN MODULATION AMONG ATHLETES
DOI:
https://doi.org/10.31435/ijitss.3(51).2026.6022Keywords:
Coanalgesics, Pain Management, Sport Trauma, Adjuvants, Pain ReliefAbstract
Introduction: Pain is one of the most common complaints associated with physical activity, both in professional and recreational sports. As a physiological and subjective phenomenon, pain serves a protective function, warning of potential injury or overuse. However, if left untreated, it may lead to chronic pain conditions, impaired motor function, or even permanent exclusion of the athlete from activity. Therefore, effective and safe pain management is essential to maintain training continuity, prevent complications, and support athletes’ optimal psychophysical performance.
Standard therapeutic approaches in athletes typically involve the use of nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, and—in the case of more severe pain—opioid medications. However, increasing attention has been paid to coanalgesics, a group of drugs that are not classified as traditional analgesics but exhibit supportive or potentiating effects on pain relief.
Coanalgesics—including antidepressants, anticonvulsants, glucocorticoids, local anesthetics, and even certain dietary supplements—are especially useful in treating neuropathic, chronic, or multifactorial pain. In the context of sports, these agents may play a crucial role in reducing the required doses of standard analgesics, minimizing side effects, and facilitating return to full physical functionality.
Given the unique characteristics of the sports environment—including time pressure, high physical demands, anti-doping regulations (e.g., WADA), and ethical considerations—appropriate analgesic selection must not only be effective but also safe, rational, and compliant with governing rules. When used appropriately, coanalgesics may serve as alternatives or adjuncts to classical pain management strategies.
Aim: The aim of this paper is to analyze the role of coanalgesics in pain therapy among athletes, with reference to data from recent clinical trials, systematic reviews, and scientific society guidelines. Particular attention is given to the efficacy, safety, and limitations of selected substances in various pain types—acute, chronic, somatic, and neuropathic—with respect to sports disciplines and return-to-play protocols.
Material and Methods: This narrative review was conducted to synthesize current evidence regarding the use of coanalgesics in the management of pain among athletes, with a particular focus on neuropathic, postoperative, and post-traumatic pain. A structured literature search was performed in PubMed, Scopus, and Web of Science.
Conclusions: Co-analgesics offer a promising tool in pain management among athletes. Paracetamol and topical analgesics may reduce pain-related limitations without the long-term risks associated with systemic agents. However, the overuse of NSAIDs and the application of opioids carry serious health and ethical concerns. Further high-quality research is needed to establish optimal treatment protocols and to promote education within sports communities.
References
Boccella, S., De Filippis, L., Giorgio, C., Brandolini, L., Jones, M., Novelli, R., Amorizzo, E., Leoni, M. L. G., Terranova, G., Maione, S., Luongo, L., Leone, M., Allegretti, M., Minnella, E. M., & Aramini, A. (2023). Combination drug therapy for the management of chronic neuropathic pain. Biomolecules, 13(12), 1802. https://doi.org/10.3390/biom13121802
Obata, H. (2017). Analgesic mechanisms of antidepressants for neuropathic pain. Int J Mol Sci, 18(11), 2483. https://doi.org/10.3390/ijms18112483
van den Driest, J. J., Bierma-Zeinstra, S. M. A., Bindels, P. J. E., & Schiphof, D. (2017). Amitriptyline for musculoskeletal complaints: A systematic review. Fam Pract, 34(2), 138–146. https://doi.org/10.1093/fampra/cmw134
Ramtin, S., & Ilyas, A. (2025). Pharmaceutical considerations in treating neuropathic pain in athletes. Int Orthop, 49(4), 951–958. https://doi.org/10.1007/s00264-025-06440-4
Forde, G. (2007). Adjuvant analgesics for the treatment of neuropathic pain: Evaluating efficacy and safety profiles. J Fam Pract, 56(2 Suppl Pain), 3–12. PMID: 17270113.
Gallagher, H. C., Gallagher, R. M., Butler, M., Buggy, D. J., & Henman, M. C. (2015). Venlafaxine for neuropathic pain in adults. Cochrane Database of Systematic Reviews, (8), CD011091. https://doi.org/10.1002/14651858.CD011091.pub2
Clauw, D. J., Mease, P., Palmer, R. H., Gendreau, R. M., & Wang, Y. (2008). Milnacipran for the treatment of fibromyalgia in adults: A 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther, 30(11), 1988–2004. Errata: Clin Ther. (2009), 31(2), 446; Clin Ther. (2009), 31(7), 1617 https://doi.org/10.1016/j.clinthera.2008.11.009
Arnold, P., Vuadens, P., Kuntzer, T., Gobelet, C., & Deriaz, O. (2008). Mirtazapine decreases the pain feeling in healthy participants. Clin J Pain, 24(2), 116–119. https://doi.org/10.1097/AJP.0b013e318159f94a
Fitridge, R., & Thompson, M. (Eds.). (2011). Mechanisms of vascular disease: A reference book for vascular specialists. University of Adelaide Press. https://www.ncbi.nlm.nih.gov/books/NBK534260/
Tomić, M., Pecikoza, U., Micov, A., Vučković, S., & Stepanović-Petrović, R. (2018). Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: Current preclinical evidence. Pharmacol Ther, 192, 42–64. https://doi.org/10.1016/j.pharmthera.2018.06.002
Lam, D. M. H., Choi, S. W., Wong, S. S. C., Irwin, M. G., & Cheung, C. W. (2015). Efficacy of pregabalin in acute postoperative pain under different surgical categories: A meta-analysis. Medicine (Baltimore), 94(46), e1944. https://doi.org/10.1097/MD.0000000000001944
Cho, E.-A., Kim, N., Lee, B., Song, J., & Choi, Y. S. (2019). The effect of perioperative pregabalin on pain after arthroscopic anterior cruciate ligament reconstruction: A randomized controlled trial. J. Clin. Med., 8, 1426. https://doi.org/10.3390/jcm8091426
van Seventer, R., Bach, F. W., Toth, C. C., Serpell, M., Temple, J., Murphy, T. K., & Nimour, M. (2010). Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: A randomized double-blind trial. Eur J Neurol, 17(8), 1082–1089. https://doi.org/10.1111/j.1468-1331.2010.02979.x
Cardenas, D. D., Nieshoff, E. C., Suda, K., Goto, S., Sanin, L., Kaneko, T., Sporn, J., Parsons, B., Soulsby, M., Yang, R., Whalen, E., Scavone, J. M., Suzuki, M. M., & Knapp, L. E. (2013). A randomized trial of pregabalin in patients with neuropathic pain due to spinal cord injury. Neurology, 80(6), 533–539. https://doi.org/10.1212/WNL.0b013e318281546b
Mardani-Kivi, M., Mobarakeh, M. K., Keyhani, S., Motlagh, K. H., & Ekhtiari, K. S. (2013). Is gabapentin effective on pain management after arthroscopic anterior cruciate ligament reconstruction? A triple blinded randomized controlled trial. Arch Bone Jt Surg, 1(1), 18–22. PMID: 25207278; PMCID: PMC4151400.
Markman, J., Resnick, M., Greenberg, S., Katz, N., Yang, R., Scavone, J., & Whalen, E. (n.d.).
Chang, L., Čok, Z., & Yu, L. (2025). Protein kinases as mediators for miRNA modulation of neuropathic pain. Cells, 14(8), 577.
Silva, A., Mourão, J., & Vale, N. (2023). A review of the lidocaine in the perioperative period. J Pers Med, 13(12), 1699. https://doi.org/10.3390/jpm13121699
Zhong, J., Hu, J., Mao, L., Ye, G., Qiu, K., Zhao, Y., & Hu, S. (2022). Efficacy of intravenous lidocaine for pain relief in the emergency department: A systematic review and meta-analysis. Front Med (Lausanne), 8, 706844. https://doi.org/10.3389/fmed.2021.706844
Dryden, B., Kerr, W. B., Higgins, S., Tou, K., & Dhanjal, S. T. (2022). The use of intravenous lidocaine as an analgesic modality in the austere environment: Two cases. Wilderness & Environmental Medicine, 33(3), 348–350. https://doi.org/10.1016/j.wem.2022.04.010
Staud, R., Weyl, E. E., Bartley, E., Price, D. D., & Robinson, M. E. (2014). Analgesic and anti-hyperalgesic effects of muscle injections with lidocaine or saline in patients with fibromyalgia syndrome. Eur J Pain, 18(6), 803–812. https://doi.org/10.1002/j.1532-2149.2013.00422.x
McMorrow, K., Allahabadi, S., Frazier, L., Quigley, R., Serrano, B., & Cole, B. J. (2023). One to two days of rest is recommended before returning to sport after intra-articular corticosteroid injection in the high-level athlete. Arthrosc Sports Med Rehabil, 5(5), 100763. https://doi.org/10.1016/j.asmr.2023.100763
Coombes, B. K., Bisset, L., & Vicenzino, B. (2010). Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: A systematic review of randomised controlled trials. In Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews. Centre for Reviews and Dissemination. https://www.ncbi.nlm.nih.gov/books/NBK79535/?utm_source=chatgpt.com
Norman, M. B., Norman, E. R., Langer, G. H., Allen, M. R., Meller, L., & Vitale, K. C. (2023). Return to sport using corticosteroid injections for knee pain in triathletes. Cureus, 15(6), e39985. https://doi.org/10.7759/cureus.39985
Drakos, M., Birmingham, P., Delos, D., Barnes, R., Murphy, C., Weiss, L., & Warren, R. (2014). Corticosteroid and anesthetic injections for muscle strains and ligament sprains in the NFL. HSS J, 10(2), 136–142. https://doi.org/10.1007/s11420-014-9395-7
Abdallah, F. W., & Sultan, P. (2023). Mechanisms of ketamine analgesia: A narrative review. Anesth Analg, 136(5), 1234–1245. https://doi.org/10.1213/ANE.0000000000006754
Johnson, R. L., Smith, T., Patel, A., et al. (2023). Low-dose ketamine infusion for postoperative opioid sparing: A randomized controlled trial. Anesth Analg, 136(3), 789–797. https://doi.org/10.1213/ANE.0000000000007228
Wong, J., Bonds, G., & Fraser, D. R. (2019). Perioperative intravenous ketamine for acute postoperative pain. Cochrane Database Syst Rev, (12), CD012712. https://doi.org/10.1002/14651858.CD012712.pub2
Steffen, R., Werlen, D., Huber, M., & Knapp, J. (2025). Dose-dependent side effects of prehospital analgesia with ketamine for winter sports injuries: An observational study. BMC Emerg Med, 25(1), 92. https://doi.org/10.1186/s12873-025-01252-6
Johnson, R. L., Smith, T., Patel, A., et al. (2023). Low-dose ketamine infusion for postoperative opioid sparing: A randomized controlled trial. Anesth Analg, 136(3), 789–797. https://doi.org/10.1213/ANE.0000000000007228
Nguyen, M. V., Thompson, Z., & Patel, P. (2023). Emerging role of ketamine in acute postoperative pain. Br J Anaesth, 130(2), 155–165. https://doi.org/10.1016/j.bja.2022.10.017
Gunduz, O. H., & Kenis-Coskun, O. (2017). Ganglion blocks as a treatment of pain: Current perspectives. J Pain Res, 10, 2815–2826.
Stanton, T. R., Wand, B. M., Carr, D. B., et al. (2016). Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev, (7), CD004598.
Stanton, T. R., Wand, B. M., Carr, D. B., et al. (2016). Local anaesthetic sympathetic blockade for complex regional pain syndrome. Cochrane Database Syst Rev, (7), CD004598.
Flisnik, M. J., et al. (2024). Lumbar sympathetic block for knee pain from synovial plica syndrome. Int Anesth Res Soc. PMID: 38949224.
Helton, A. K., et al. (1995). Effect of sympathetic nerve block on acute inflammatory pain and hyperalgesia. Anesthesiology, 82(4), 877–883.
Cho, D. H., Li, J., & Nazarian, A. (2021). Ultrasound-guided stellate ganglion block with preserved motor function for upper extremity surgery. Cureus, 13(10), e18537. https://doi.org/10.7759/cureus.18537
Anesth Analg. (2011). Local anesthetic blockade of peripheral nerves for neuralgia. Anesth Analg. at.
Zhang, T., Adatia, A., Zarin, W., et al. (2011). The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: A systematic review and meta-analysis. Inflammopharmacology, 19(1), 21–34. PMID: 21076878.
Sports medicine narrative review: BoNT-A applications. (2020). Orthopedics and Sports Medicine: Open Access Journal, 3(4). https://doi.org/10.32474/OSMOAJ.2020.03.000169
Dewan Md, S., Khan, Z. A., Nila, I. S., et al. (2024). Effects of botulinum toxin-A for spasticity and nociceptive pain in SCI individuals: Systematic review and meta-analysis. Ann Rehabil Med, 48(3), 192–202. PMCID: PMC11217759.
Use of botulinum toxin in musculoskeletal pain. (n.d.). PMCID: PMC3968894; PMID: 24967105.
Use of botulinum toxin in back pain. (2024). Quality in Sport.
Cezar, L., Wang, Q., & Chen, H. (2022). Bisphosphonates for bone edema and sports-related injuries. Front Sports Med, 2, 16.
Chiodo, S., & Zelicoff, M. (2011). Use of bisphosphonates for the treatment of stress fractures in athletes. Knee Surg Sports Traumatol Arthrosc, 19(5), 143–145. PMID: 21358506.
Smith, A., & Jones, B. (2023). Intravenous ibandronate in professional athletes with bone marrow oedema: Retrospective cohort. Clin J Sport Med, 33(2), 112–118.
Li, Z., Luo, W., & Xu, H. (2021). Bisphosphonates for osteoarthritis pain: Systematic review. J Orthop Surg Res, 16(1), 445. PMID: 34215993.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Anna Nowak, Tomasz Woźniak, Zuzanna Filipiak, Maria Golińska, Piotr Dudziak, Łukasz Wabiszczewicz, Marcin Masłowski, Natalia Wasilewska, Natalia Kita, Alicja Sokołowska, Tomasz Mróz
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
